218 related articles for article (PubMed ID: 33661960)
1. Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay.
Higgins RL; Rawlings SA; Case J; Lee FY; Chan CW; Barrick B; Burger ZC; Yeo KJ; Marrinucci D
PLoS One; 2021; 16(3):e0247797. PubMed ID: 33661960
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
[TBL] [Abstract][Full Text] [Related]
3. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
[TBL] [Abstract][Full Text] [Related]
4. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
[TBL] [Abstract][Full Text] [Related]
5. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities.
Orner EP; Rodgers MA; Hock K; Tang MS; Taylor R; Gardiner M; Olivo A; Fox A; Prostko J; Cloherty G; Farnsworth CW
Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115300. PubMed ID: 33388575
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Longitudinal Evaluation of Six Commercial Immunoassays for the Detection of IgM and IgG Antibodies against SARS CoV-2.
Nedelcu I; Jipa R; Vasilescu R; Băicuș C; Popescu CI; Manea E; Stoichițoiu LE; Pinte L; Damalan A; Simulescu O; Stoica I; Stoica M; Hristea A
Viruses; 2021 Jun; 13(7):. PubMed ID: 34206895
[TBL] [Abstract][Full Text] [Related]
7. Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.
Indenbaum V; Koren R; Katz-Likvornik S; Yitzchaki M; Halpern O; Regev-Yochay G; Cohen C; Biber A; Feferman T; Cohen Saban N; Dhan R; Levin T; Gozlan Y; Weil M; Mor O; Mandelboim M; Sofer D; Mendelson E; Lustig Y
PLoS One; 2020; 15(11):e0241164. PubMed ID: 33227020
[TBL] [Abstract][Full Text] [Related]
8. Monitoring Specific IgM and IgG Production Among Severe COVID-19 Patients Using Qualitative and Quantitative Immunodiagnostic Assays: A Retrospective Cohort Study.
Al-Mughales JA; Al-Mughales TJ; Saadah OI
Front Immunol; 2021; 12():705441. PubMed ID: 34539635
[TBL] [Abstract][Full Text] [Related]
9. Serological evaluation of patients with coronavirus disease-2019 in Daegu, South Korea.
Park S; Chang SH; Lee JH; Lee JH; Ham JY; Kim YK; Kim SG; Ryoo NH
PLoS One; 2022; 17(1):e0262820. PubMed ID: 35051239
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the serological detection of IgG and IgM to SARS-Cov-2: a prospective, cross-sectional study.
Pecoraro V; Cassetti T; Meacci M; Gargiulo R; Capobianchi MR; Mussini C; Vecchi E; Pecorari M; Gagliotti C; Trenti T; Sarti M
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1891-1898. PubMed ID: 33839972
[TBL] [Abstract][Full Text] [Related]
11. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
[TBL] [Abstract][Full Text] [Related]
12. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
Zervou FN; Louie P; Stachel A; Zacharioudakis IM; Ortiz-Mendez Y; Thomas K; Aguero-Rosenfeld ME
J Med Virol; 2021 Sep; 93(9):5409-5415. PubMed ID: 33932299
[TBL] [Abstract][Full Text] [Related]
14. Antibody tests for identification of current and past infection with SARS-CoV-2.
Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
[TBL] [Abstract][Full Text] [Related]
15. False-positive results of SARS-CoV-2 IgM/IgG antibody tests in sera stored before the 2020 pandemic in Italy.
Latiano A; Tavano F; Panza A; Palmieri O; Niro GA; Andriulli N; Latiano T; Corritore G; Gioffreda D; Gentile A; Fontana R; Guerra M; Biscaglia G; Bossa F; Carella M; Miscio G; di Mauro L
Int J Infect Dis; 2021 Mar; 104():159-163. PubMed ID: 33383223
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
Zhou C; Bu G; Sun Y; Ren C; Qu M; Gao Y; Zhu Y; Wang L; Sun L; Liu Y
J Med Virol; 2021 May; 93(5):2857-2866. PubMed ID: 33331654
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect.
Maine GN; Lao KM; Krishnan SM; Afolayan-Oloye O; Fatemi S; Kumar S; VanHorn L; Hurand A; Sykes E; Sun Q
J Clin Virol; 2020 Dec; 133():104663. PubMed ID: 33161369
[TBL] [Abstract][Full Text] [Related]
18. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
[TBL] [Abstract][Full Text] [Related]
19. Clinical Performance of SARS-CoV-2 IgG and IgM Tests Using an Automated Chemiluminescent Assay.
Zhou JA; Zeng HL; Deng LY; Li HJ
Curr Med Sci; 2021 Apr; 41(2):318-322. PubMed ID: 33877548
[TBL] [Abstract][Full Text] [Related]
20. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response.
David A; Scott L; Jugwanth S; Gededzha M; Kahamba T; Zwane N; Mampeule N; Sanne I; Stevens W; Mayne ES
J Immunol Methods; 2021 Sep; 496():113096. PubMed ID: 34242653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
